UNSPSC 85632130: Replacement of right nipple with synthetic substitute, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to replacement of right nipple with synthetic substitute, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0HRW3JZ

UNSPSC 85632130, Replacement of right nipple with synthetic substitute, percutaneous approach (Commodity), does not reflect the actual work being solicited under this code in state and local procurement. Recent opportunities tagged with this code cover occupational and disability medical surveillance, pharmacy benefit management, temporary health professional staffing, and surgical benefit program administration—none of which involve the specific surgical procedure named in the code. The mismatch between the code's clinical nomenclature and the scope of recent solicitations suggests either systematic misclassification by issuing bodies or a gap between UNSPSC's medical-device taxonomy and the way state and local procurement offices classify healthcare services and staffing.

The geographic spread of recent activity is limited. The Washington State Department of Transportation, the City of Phoenix Retirement Office, the City of Long Beach, Harris County Juvenile Probation Department (Texas), Collier County (Florida), and the County of Santa Clara Health System (California) represent the issuing bodies in the source block. No state or jurisdiction appears more than once. Representative recent opportunities include WSDOT's occupational medical surveillance RFP due October 9, 2026, covering examinations for ferry workers across 14 Washington locations; the City of Phoenix's disability medical evaluation services RFP due October 16, 2026, with a $750,000 five-year maximum; and the County of Santa Clara's non-exclusive temporary health professional staffing pool RFP due October 7, 2026, spanning ancillary clinical categories. Without additional corroboration that this code is being used intentionally and consistently, treating opportunities under this code as a reliable market signal carries significant risk.